|
1
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saika K and Machii R: Cancer mortality
attributable to tobacco by region based on the WHO Global Report.
Jpn J Clin Oncol. 42:771–772. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stinchcombe TE and West HL: Maintenance
therapy in non-small-cell lung cancer. Lancet. 374:1398–1400. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang A: Chemotherapy, chemoresistance and
the changing treatment landscape for NSCLC. Lung cancer. 71:3–10.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kovalchuk O, Filkowski J, Meservy J,
Ilnytskyy Y, Tryndyak VP, Chekhun VF and Pogribny IP: Involvement
of microRNA-451 in resistance of the MCF-7 breast cancer cells to
chemotherapeutic drug doxorubicin. Mol Cancer Ther. 7:2152–2159.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song B, Wang Y, Titmus MA, Botchkina G,
Formentini A, Kornmann M and Ju J: Molecular mechanism of
chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
Mol Cancer. 9:962010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hummel R, Hussey DJ and Haier J:
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in
different tumour types. Eur J Cancer. 46:298–311. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huh JH, Kim TH, Kim K, Song JA, Jung YJ,
Jeong JY, Lee MJ, Kim YK, Lee DH and An HJ: Dysregulation of
miR-106a and miR-591 confers paclitaxel resistance to ovarian
cancer. Br J Cancer. 109:452–461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang PY, Li YJ, Zhang S, Li ZL, Yue Z, Xie
N and Xie SY: Regulating A549 cells growth by ASO inhibiting miRNA
expression. Mol Cell Biochem. 339:163–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Locher KP: Structure and mechanism of ABC
transporters. Curr Opin Struct Biol. 14:426–431. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iwasaki H, Okabe T, Takara K, Yoshida Y,
Hanashiro K and Oku H: Down-regulation of lipids transporter ABCA1
increases the cytotoxicity of nitidine. Cancer Chemother Pharmacol.
66:953–959. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Borst P, Evers R, Kool M and Wijnholds J:
A family of drug transporters: the multidrug resistance-associated
proteins. J Natl Cancer Inst. 92:1295–1302. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cole SP, Bhardwaj G, Gerlach JH, Mackie
JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and
Deeley RG: Overexpression of a transporter gene in a
multidrug-resistant human lung cancer cell line. Science.
258:1650–1654. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deeley RG and Cole SP: Function, evolution
and structure of multidrug resistance protein (MRP). Semin Cancer
Biol. 8:193–204. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang Y, Shen H, Li H, et al: miR-106a
confers cisplatin resistance by regulating PTEN/Akt pathway in
gastric cancer cells. Acta Biochim Biophys Sin (Shanghai).
2013.45(11): 963–72
|
|
19
|
Gong C, Yao Y, Wang Y, Liu B, Wu W, Chen
J, Su F, Yao H and Song E: Up-regulation of miR-21 mediates
resistance to trastuzumab therapy for breast cancer. J Biol Chem.
286:19127–19137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S,
Lee TJ, Kim T, Bakàcs A, Alder H, Kaur B, et al: MicroRNAs/TP53
feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci
USA. 109:5316–5321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong Z, Zhong Z, Yang L, Wang S and Gong
Z: MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small
cell lung cancer cells by regulating the drug transporter ABCB9.
Cancer Lett. 343:249–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Li L, Guan Y, Liu X, Meng Q and Guo
Q: MiR-92b regulates the cell growth, cisplatin chemosensitivity of
A549 non small cell lung cancer cell line and target PTEN. Biochem
Biophys Res Commun. 440:604–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song L, Li Y, Li W, Wu S and Li Z: miR-495
enhances the sensitivity of non-small cell lung cancer cells to
platinum by modulation of copper-transporting P-type adenosine
triphosphatase A (ATP7A). J Cell Biochem. 115:1234–1242. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gillet JP, Efferth T and Remacle J:
Chemotherapy-induced resistance by ATP-binding cassette transporter
genes. Biochim Biophys Acta. 1775:237–262. 2007.PubMed/NCBI
|
|
25
|
Yamagishi T, Sahni S, Sharp DM, Arvind A,
Jansson PJ and Richardson DR: P-glycoprotein mediates drug
resistance via a novel mechanism involving lysosomal sequestration.
J Biol Chem. 288:31761–31771. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dai DW, Lu Q, Wang LX, Zhao WY, Cao YQ, Li
YN, Han GS, Liu JM and Yue ZJ: Decreased miR-106a inhibits glioma
cell glucose uptake and proliferation by targeting SLC2A3 in GBM.
BMC Cancer. 13:4782013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Z, Gersbach E, Zhang X, Xu X, Dong R,
Lee P, Liu J, Kong B, Shao C and Wei JJ: miR-106a represses the Rb
tumor suppressor p130 to regulate cellular proliferation and
differentiation in high-grade serous ovarian carcinoma. Mol Cancer
Res. 11:1314–1325. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhi F, Zhou G, Shao N, Xia X, Shi Y, Wang
Q, Zhang Y, Wang R, Xue L, Wang S, et al: miR-106a-5p inhibits the
proliferation and migration of astrocytoma cells and promotes
apoptosis by targeting FASTK. PLoS One. 8:e723902013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee BH, Taylor MG, Robinet P, et al:
Dysregulation of cholesterol homeostasis in human prostate cancer
through loss of ABCA1. Cancer Res. 73:1211–1218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Smith B and Land H: Anticancer activity of
the cholesterol exporter ABCA1 gene. Cell Rep. 2:580–590. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bachmeier BE, Iancu CM, Killian PH,
Kronski E, Mirisola V, Angelini G, Jochum M, Nerlich AG and Pfeffer
U: Overexpression of the ATP binding cassette gene ABCA1 determines
resistance to Curcumin in M14 melanoma cells. Mol Cancer.
8:1292009. View Article : Google Scholar : PubMed/NCBI
|
